5-hydroxytryptophan has been researched along with imiquimod in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hsu, PY; Su, CC; Yang, HJ; Yang, TH | 1 |
1 other study(ies) available for 5-hydroxytryptophan and imiquimod
Article | Year |
---|---|
5-hydroxytryptophan attenuates imiquimod-induced psoriasiform dermatitis probably through inhibition of IL-17A production and keratinocyte activation.
Topics: 5-Hydroxytryptophan; Animals; CD4-Positive T-Lymphocytes; Cell Differentiation; Cell Line; Cyclooxygenase 2; Disease Models, Animal; Epidermis; Humans; Imiquimod; Interferon-gamma; Interleukin-17; Interleukin-6; Keratinocytes; Ki-67 Antigen; Male; Mice; Mice, Inbred C57BL; Protein Biosynthesis; Psoriasis; Spleen; Tumor Necrosis Factor-alpha | 2018 |